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Fusobacterium Nucleatum, a New Invasive 
Pathogen in Neutropenic Patients?
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ED J. KUIJPER2
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Academic Medical Centre, Amsterdam; and the 3Department of Medical Microbiology, University Hospital, Nijmegen,
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Three chemotherapy-induced neutropenic hematologic patients with severe systemic infection caused by Fusobacterium 
nucleatum, a Gram-negative anaerobic rod, are described. Anaerobic infections are not very common in this patient category, 
but in a short period of time, several such patients were seen. The infection was considered to be caused by a combination of 
chemotherapy-induced mucositis, which served as a portal o f entry for the systemic infection, and the antibiotic regime used 
in these patients. This is a serious infection with a high mortality. In hematological neutropenic patients suffering from severe 
mucositis and fever, antibiotic therapy should cover anaerobic bacteria.
P. M. Landsaat, MD, F4-119, Academic Médical Center, Meibevgdreef 9, 1105 A Z  Amsterdatn-ZO, The Netherlands
INTRODUCTION
Anaerobic bacteria infrequently cause systemic infection in 
hematological patients with neutropenia following chemo­
therapy ( 1). Recently 3 neutropenic patients with severe oro­
pharyngeal mucositis developed systemic infection caused by 
Fusobacterium nucleatum, a Gram-negative anaerobic rod.
CASE REPORTS
Case I
Patient A, a 44-year-old female, underwent an autologous bone 
marrow transplantation as a consolidation treatment for a refrac­
tory anemia with blast excess. Myelo-ablative chemotherapy con­
sisted of etoposide and dimethylbusulphan. As standard infection 
prophylaxis, oral ciprofloxacin 2 x 500 mg, oral amphotericin-B 
4 x 500 mg and benzylpenicillin 4 x 10r’TU i.v. was given, the latter 
to prevent streptococcal septicemia. On day 12, mucositis grade 4 
on the WHO scale developed. On day 14, penicillin was replaced 
by vancomycin because of high fever and the. suspicion of a central 
venous catheter associated infection. On day 29, an inspiratory 
stridor developed and intubation was necessary. Blood cultures 
were positive for F. nucleatum. Antibiotic therapy was changed to 
metronidazole and cephalothin. Mucosal damage progressed and a 
pulmonary infiltrate developed. The bone marrow remained aplas­
tic. On the 36th day after transplantation the patient succumbed. 
Post-mortem examination revealed a damaged and necrotic mu­
cosa of the throat and the upper respiratory tract, which contained 
many fusiform Gram-negative rods.
Case 2
Patient B was a 29-year-old female with a myelodysplastic syn­
drome requiring a large number of blood transfusions, and severe 
thrombocytopenia. Chemotherapy consisted of idurubicin, ara-c 
and etoposide. Standard infection prophylaxis was given. On the 
16th day, she developed fever with grade 3 mucositis and swelling 
of the neck. The neutrophil count at that time was <0.1 x 109/1. 
Blood cultures revealed only Staphylococcus epidermidis and van­
comycin was given. The fever abated and the general condition of 
the patient improved, although the mucositis and bone marrow 
aplasia persisted. On the 46th day she again developed higher 
fever. Blood cultures revealed F. nucleatum for which clindamycin
4 x 600 mg i.v. was added. Fever and bone marrow hypoplasia 
persisted and she developed pulmonary infiltrates for which treat­
ment was started with amphotericin-B i.v. She died on the 77th 
day. Postmortem examination revealed pulmonary aspergillosis.
Case 3
Patient C was a 44-year-old man with a secondary myelodysplastic 
syndrome after treatment for Hodgkin’s disease. Chemotherapy 
consisted of idarubicin, etoposide and Ara-C. He received standard 
infection prophylaxis, but because of penicillin allergy, vancomycin 
was given. On the 16th day, grade 4 mucositis (WHO) developed, 
followed by high fever. Blood cultures revealed F. nucleatum for 
which he was treated with cephalothin. After 5 days the tempera­
ture normalized and his mucositis and neutrophils recovered. He 
achieved complete remission.
Microb io logical da ta
F, nucleatum was identified by conventional bacteriological meth­
ods and by gas-liquid chromatography. The strains were suscepti­
ble to benzyl penicillin, cephalothin, clindamycin and 
metronidazole, but resistant to ciprofloxacin and erythromycin. 
They were all p-lactamase-negative,
DISCUSSION
Three patients with systemic infection caused by F. nuclea­
tum are described. All had severe chemotherapy-induced 
neutropenia and high fever. In the only patient surviving the 
infection, bone marrow recovery was probably a significant 
factor. There is resemblance to post-anginal septicemia 
(Lemierre’s Syndrome, 2) described in 1936 in healthy young 
adults, usually caused by F. necrophorum.
F. nucleatum is a strictly anaerobic Gram-negative rod 
normally found in the gastrointestinal, genito-urinary 
and respiratory tracts. We have no reason to assume that 
this sudden increase is due to better culture- methods, 
to transmission by personal contact, or to contaminated food.
All 3 patients received our standard infection prophyl­
axis. For various reasons, penicillin was replaced by van­
comycin to prevent endogenic streptococcal infections. This
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infection prophylaxis is not active against F. nucleatum and 
may have resulted in a selection and overgrowth of it.
All patients received very intensive chemotherapy leading 
to a severe mucositis. F. nucleatum might have exacerbated 
an oropharyngeal mucositis that could serve as a portal of 
entry for the systemic infection.
In patients with fever and severe mucositis, early treat­
ment with antibiotics directed at anaerobes should be con­
sidered.
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